Cours Bausch Health Companies Inc Toronto S.E.
Actions
CA91911K1021
Produits pharmaceutiques
CA 2024 * | 9,39 Md 12,83 Md 8,57 Md | CA 2025 * | 9,45 Md 12,92 Md 8,63 Md | Capitalisation | 3,19 Md 4,37 Md 2,92 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 336 M 459 M 307 M | Résultat net 2025 * | 381 M 521 M 348 M | VE / CA 2024 * | 2,46 x |
Dette nette 2024 * | 19,91 Md 27,21 Md 18,18 Md | Dette nette 2025 * | 18,33 Md 25,05 Md 16,74 Md | VE / CA 2025 * | 2,28 x |
PER 2024 * |
13,2
x | PER 2025 * |
8,46
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 97,66% |
Dernier transcript sur Bausch Health Companies Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24/05/22 |
Chief Operating Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01/08/08 |
John Paulson
CHM | Chairman | 68 | 01/06/17 |
Steven Miller
BRD | Director/Board Member | 35 | 17/03/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+27,00% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+13,09% | 231 Md | |
+5,46% | 200 Md | |
-9,61% | 195 Md | |
-6,26% | 145 Md |